Related Experiment Video
Updated: Mar 13, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Reversible cardiomyopathy secondary to Amphotericin-B
Antonio Carlos Bandeira1, José Magalhães Filho2, Karine de Almeida Ramos2
1Faculdade de Tecnologia e Ciencias Medical School, Hospital Couto Maia, Rua São Francisco s/n Monte Serrat, Zip 40425-060 Salvador, Bahia, Brazil.
Abstract:
We describe a 32-yr old woman with AIDS and cryptococcal meningitis that developed cardiomyopathy after 17 days of treatment with Deoxycholate Amphotericin-B (D-Amb) with reversal of the symptoms and transthoracic echocardiogram (TTE) findings after the drug had been stopped and switched to Fluconazole.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Myocarditis I: Introduction
